Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine.
Sarah E ConwayShrishti SaxenaClare Baecher-AllanRajesh KrishnanMaria K HoutchensBonnie I GlanzTaylor J SaracenoMariann Polgar-TurcsanyiGauruv BoseRohit BakshiShamik BhattacharyyaKristin GalettaTamara KaplanChristopher SeversonTarun SinghalLynn StazzoneJonathan ZurawskiAnu PaulHoward L WeinerBrian C HealyTanuja ChitinisPublished in: Multiple sclerosis journal - experimental, translational and clinical (2023)
NCT05060354.